These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2531002)

  • 1. Dissection of the effector-binding site and complementation studies of Escherichia coli phosphofructokinase using site-directed mutagenesis.
    Lau FT; Fersht AR
    Biochemistry; 1989 Aug; 28(17):6841-7. PubMed ID: 2531002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-directed mutagenesis in the effector site of Escherichia coli phosphofructokinase.
    Lau FT; Fersht AR; Hellinga HW; Evans PR
    Biochemistry; 1987 Jun; 26(13):4143-8. PubMed ID: 2958087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of allosteric inhibition to activation in phosphofructokinase by protein engineering.
    Lau FT; Fersht AR
    Nature; 1987 Apr 23-29; 326(6115):811-2. PubMed ID: 2952886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of residue 161 in the allosteric transitions of two bacterial phosphofructokinases.
    Auzat I; Byrnes WM; Garel JR; Chang SH
    Biochemistry; 1995 May; 34(21):7062-8. PubMed ID: 7766616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed mutagenesis identifies catalytic residues in the active site of Escherichia coli phosphofructokinase.
    Berger SA; Evans PR
    Biochemistry; 1992 Sep; 31(38):9237-42. PubMed ID: 1390710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of glycine 212 in the allosteric behavior of phosphofructokinase from Bacillus stearothermophilus.
    Zhu X; Byrnes M; Nelson JW; Chang SH
    Biochemistry; 1995 Feb; 34(8):2560-5. PubMed ID: 7873536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MgATP-dependent activation by phosphoenolpyruvate of the E187A mutant of Escherichia coli phosphofructokinase.
    Pham AS; Reinhart GD
    Biochemistry; 2001 Apr; 40(13):4150-8. PubMed ID: 11300796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disentangling the web of allosteric communication in a homotetramer: heterotropic inhibition in phosphofructokinase from Escherichia coli.
    Fenton AW; Reinhart GD
    Biochemistry; 2009 Dec; 48(51):12323-8. PubMed ID: 19905012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing an allosterically locked phosphofructokinase.
    Kundrot CE; Evans PR
    Biochemistry; 1991 Feb; 30(6):1478-84. PubMed ID: 1825177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent binding of MgADP to the E187A mutant of Escherichia coli phosphofructokinase in the absence of allosteric effects.
    Pham AS; Janiak-Spens F; Reinhart GD
    Biochemistry; 2001 Apr; 40(13):4140-9. PubMed ID: 11300795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric activation increases the maximum velocity of E. coli phosphofructokinase.
    Auzat I; Le Bras G; Garel JR
    J Mol Biol; 1997 Apr; 267(3):476-80. PubMed ID: 9126831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reevaluation of the accepted allosteric mechanism of phosphofructokinase from Bacillus stearothermophilus.
    Kimmel JL; Reinhart GD
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):3844-9. PubMed ID: 10759544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of substrate contact residues important for the allosteric regulation of phosphofructokinase from Eschericia coli.
    Fenton AW; Paricharttanakul NM; Reinhart GD
    Biochemistry; 2003 Jun; 42(21):6453-9. PubMed ID: 12767227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH dependence of the kinetic properties of allosteric phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Bourgain F; Garel JR
    Biochemistry; 1991 Jun; 30(23):5750-4. PubMed ID: 1828369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific suppression of heterotropic interactions in phosphofructokinase by the mutation of leucine 178 into tryptophan.
    Serre MC; Teschner W; Garel JR
    J Biol Chem; 1990 Jul; 265(21):12146-8. PubMed ID: 2142686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of an individual allosteric interaction in tetrameric phosphofructokinase from Bacillus stearothermophilus.
    Kimmel JL; Reinhart GD
    Biochemistry; 2001 Sep; 40(38):11623-9. PubMed ID: 11560513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible high hydrostatic pressure inactivation of phosphofructokinase from Escherichia coli.
    Deville-Bonne D; Else AJ
    Eur J Biochem; 1991 Sep; 200(3):747-50. PubMed ID: 1833191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutagenesis of the regulatory domain of Escherichia coli carbamoyl phosphate synthetase identifies crucial residues for allosteric regulation and for transduction of the regulatory signals.
    Fresquet V; Mora P; Rochera L; Ramón-Maiques S; Rubio V; Cervera J
    J Mol Biol; 2000 Jun; 299(4):979-91. PubMed ID: 10843852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the C-terminal region in the allosteric properties of Escherichia coli phosphofructokinase-1.
    Serre MC; Garel JR
    Eur J Biochem; 1990 May; 189(3):487-92. PubMed ID: 2140983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proteolyzed derivative of Escherichia coli phosphofructokinase is no longer sensitive to allosteric effectors and still shows cooperativity in substrate binding.
    Le Bras G; Garel JR
    Biochemistry; 1982 Dec; 21(26):6656-60. PubMed ID: 6218818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.